Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery

Chest

Volumn 109, Issue 6, 1996, Pages 1556-1561

  DeRiso II, Anthony J ^a,b   Ladowski, Joseph S ^a   Dillon, Todd A ^a   Justice, John W ^a   Peterson, Alan C ^a  

^a Lutheran Hospital Fort Wayne   (United States)

^b Indiana/Ohio Heart   (United States)

Author keywords

antibiotic use; chlorhexidine gluconate 0.12 oral rinse; heart surgery; infection control; mechanical ventilation; nosocomial infection; oropharyngeal decontamination; respiratory infection; selective decontamination of the digestive tract

Indexed keywords

CEFUROXIME; CHLORHEXIDINE GLUCONATE; RANITIDINE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST CONTROL; DOUBLE BLIND PROCEDURE; FEMALE; HEART SURGERY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; ORAL DRUG ADMINISTRATION; OROPHARYNX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

EID: 0029931655     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.6.1556     Document Type: Article

References (33)

1. Aerdts SJA, van Daelen R, Clasener HAL, et al. Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients: a prospective, blinded, randomized trial of the effect of a novel regimen. Chest 1991; 100:783-91
2. Flaherty J, Nathan C, Kabins SA, et al. Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis 1990; 162:1393-97
3. Hartenauer U, Thulig B, Diemer W, et al. Effect of selective flora suppression on colonization, infection, and mortality in critically ill patients: a 1-year, prospective consecutive study. Crit Care Med 1991; 19:463-73
4. Ledingham IM, Alcock SR, Eastaway AT, et al. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1988; 1:785-90
5. Pugin J, Auckenthaler R, Lew DP, et al. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia: a randomized, placebo-controlled, double-blind clinical trial. JAMA 1991; 265:2704-10
6. Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A, et al. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 1990; 18:1239-42
7. Stoutenbeek CP, van Saene HKF. Miranda DB, et al. The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med 1984; 10:185-92
8. Ulrich C, Harinck-de Weerd JE, Bakker NC, et al. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive Care Med 1989; 15:424-31
9. Unertl K, Ruckdeschel C, Selbmann HK, et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 13:106-13
10. Gastinne H, Wolff M, Delatour F, et al. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992; 326:594-99
11. Selective decontamination of the digestive tract trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307:525-32
12. Greenfield S, Teres D, Bushnell LS, et al. Prevention of Gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. J Clin Invest 1973; 52:2935-40
13. Klastersky J, Huysmans E, Werts D, et al. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 1974; 65:650-54
14. Klick JM, du Moulin GC, Hedley-Whyte J, et al. Prevention of Grain-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. J Clin Invest 1975; 55:514-19
15. Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med 1968; 68:579-90
16. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multi-resistant Gram-negative bacilli: study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110:873-81
17. Nau R, Ruchel B, Mergerian H, et al. Emergence of antibiotic resistant bacteria during selective decontamination of the digestive tract. J Antimicrob Chemother 1990; 25:881-83
18. Rocha LA, Martin MJ, Pita S, et al. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. Intensive Care Med 1992; 18:398-404
19. Cerra FB, Maddaus MA, Dunn DL, et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992; 127:163-69
20. Briner WW, Grossman E, Buckner RY, et al. Effect of chlorhexidine gluconate mouthrinse on plaque bacteria. J Periodontal Res 1986; 21(suppl 16)44-52
21. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance. 1984. MMWR 1986; 35:17SS-29SS
22. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40
23. Guidelines for prevention of nosocomial pneumonia: Centers for Disease Control and Prevention. Respir Care 1994; 39:1191-1236
24. Johanson WG, Siedenfeld JJ, Gomez P, et al. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137:259-64
25. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-29
26. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 135:426-32
27. Veksler AE, Kayrouz GA, Newman MG. Reduction of salivary bacteria by pre-procedural rinses with chlorhexidine 0.12%. J Periodontol 1991; 62:649-51
28. Rutkauskas JS, David JW. Effects of chlorhexidine during immunosuppressive chemotherapy. Oral Surg Oral Med Oral Pathol 1993; 76:441-48
29. Sharon A, Berdicevsky I, Ben-Arych H, et al. The effect of chlorhexidine mouthrinse on oral candida in a group of leukemia patients. Oral Surg Oral Med Oral Pathol 1977; 44:201-05
30. Briner WW, Grossman E, Buckner RY, et al. Assessment of susceptibility of plaque bacteria to chlorhexidine after 6 months oral use. J Periodontal Res 1986; 21(suppl 16)53-9
31. Bernstein D, Schiff G, Echler G, et al. In vitro virucidal effectiveness of a 0.12% chlorhexidine gluconate mouthrinse. J Dent Res 1990; 69:874-76
32. Park NH, Park JP, Min BM, et al. Combined synergistic antiherpetic effect of acyclovir and chlorhexidine in vivo. Oral Surg Oral Med Oral Pathol 1991; 71:193-96
33. Thurmonal JM, Brown AT, Sims RE, et al. Oral Candida albicans in bone marrow transplant recipients given chlorhexidine rinses: occurrence and susceptibilities to the agent. Oral Surg Oral Med Oral Pathol 1991; 72:291-95